Hint mode is switched on Switch off
For swift navigation between sections

Baxalta Inc
LEI 5493000JW8DCO3T45R55

Organization name
Baxalta Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
  • M/S&P/F
    *** / *** / ***
Public debt
500 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Baxalta Inc is a global biopharmaceutical leader. The Company works across disease areas, including hemophilia, immunology and oncology. As of June 3, 2016, Baxalta Incorporated operates as a subsidiary of Shire plc.

Awards

Documentation

IFRS/US GAAP reports

2016
2015
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    5493000JW8DCO3T45R55
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • ICB
    4,500 Health Care
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001620546
Registration is required to get access.